missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human VASH1 Synthetic Peptide
Synthetic Peptide
Brand: Invitrogen™ PEP1262
This item is not returnable.
View return policy
Description
VASH1 Synthetic Peptide, PEP-1262, from Invitrogen.
VASH1 is a protein that possesses actin binding activity and metallocarboxypeptidase activity. It is involved in several processes including negative regulation of angiogenesis, negative regulation of blood vessel endothelial cell migration, and proteolysis. VASH1 acts upstream of or within processes such as negative regulation of endothelial cell migration, negative regulation of endothelial cell proliferation, and negative regulation of lymphangiogenesis. It is located in the apical part of the cell, endoplasmic reticulum, and extracellular space. VASH1 is implicated in liver cirrhosis and portal hypertension, and is a biomarker of liver cirrhosis. Diseases associated with VASH1 include Portal Hypertension and Myasthenic Syndrome, Congenital, 14.
Specifications
| 22846 | |
| purified | |
| Human VASH1 | |
| -20°C | |
| Liquid | |
| Blocking Assay, Control | |
| No | |
| Peptide | |
| RUO - research use only |
| Human | |
| Q7L8A9 | |
| 200 μg/mL | |
| Synthetic Peptide | |
| PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 | |
| VASH1 | |
| 0.02% sodium azide | |
| 50 μg | |
| PBS |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Invitrogen™ Human VASH1 Synthetic Peptide > 50 μg; Unlabeled
Spot an opportunity for improvement?Share a Content Correction
